Pulmonary embolism, metalloproteinases and neutrophil gelatinase associated lipocalin

Acta Phlebologica

Volumn 14, Issue 3, 2013, Pages 115-121

  Busceti, M T ^a   Grande, R ^a   Amato, B ^a,b   Gasbarro, V ^a,c   Buffone, G ^a   Amato, M ^b   Gallelli, L ^a   Serra, R ^a   De Franciscis, S ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Metalloproteinases; Pulmonary embolism; Venous thromboembolism

Indexed keywords

EID: 84894252996     PISSN: 1593232X     EISSN: 18271766     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(23 Suppl 1):I4-8. (Pubitemid 41289265)
2. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009;123(Suppl 4):S11-7.
3. Spyropoulos AC, Lin J. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations. J Manag Care Pharm 2007;13:475-86. (Pubitemid 350193368)
4. Lefebvre P, Laliberté F, Nutescu EA, Duh MS, LaMori J, Bookhart BK et al. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries. J Manag Care Pharm 2012;18:363-74.
5. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 2013;119:648-55.
6. Sadosty AT, Boie ET, Stead LG. Pulmonary embolism. Emerg Med Clin North Am 2003;21:363-84. (Pubitemid 36644722)
7. British Thoracic Society Standards of Care Committee Pulmonary Embolism Guideline Development Group. British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax 2003;58:470-83.
8. Jain S, Aggarwal R, Arora N. Pulmonary embolism. J Indian Med 2010;108:222, 227-30, 232.
9. Das S, Mandal M, Chakraborti T, Mandal A, Chakraborti S. Isolation of MMP-2 from MMP-2/TIMP-2 complex: characterization of the complex and the free enzyme in pulmonary vascular smooth muscle plasma membrane. Biochim Biophys Acta 2004;1674:158-74.
10. Briasoulis A, Tousoulis D, Papageorgiou N, Kampoli AM, Androulakis E, Antoniades C et al. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease. Curr Top Med Chem 2012;12:1214-21.
11. Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med 2012;33:119-208.
12. Mühl D, Ghosh S, Uzuelli JA, Lantos J, Tanus-Santos JE. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism. Thromb Res 2010;125:549-53.
13. Dewyer NA, Sood V, Lynch EM, Luke CE, Upchurch GR Jr, Wakefield TW et al. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution. J Surg Res 2007;142:357-63. (Pubitemid 47418837)
14. Zhang YB, Li W, Yao LQ, Zhao XL, Wang B, Li HK et al. Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis. Chin J Traumatol 2010;13:188-92.
15. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J 2008;156:308-14.
16. Thakker-Varia S, Tozzi CA, Poiani GJ, Babiarz JP, Tatem L, Wilson FJ et al. Expression of matrix-degrading enzymes in pulmonary vascular remodeling in the rat. Am J Physiol 1998;275(2 Pt 1):L398-406.
17. Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR et al. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 2005;42:140-8. (Pubitemid 40966087)
18. Sood V, Luke CE, Deatrick KB, Baldwin J, Miller EM, Elfline M et al. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb Haemost 2010;104:1174-83.
19. Zucker S, Doshi K, Cao J. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. Adv Clin Chem 2004;38:37-85. (Pubitemid 39753884)
20. Souza-Costa DC, Figueiredo-Lopes L, Alves-Filho JC, Semprini MC, Gerlach RF, Cunha FQ et al. Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. Crit Care Med 2007;35:239-45. (Pubitemid 46035701)
21. Jiménez D, Yusen RD. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Curr Opin Pulm Med 2008;14:414-21.
22. Aujesky D, Roy PM, Le Manach CP, Verschuren F, Meyer G, Obrosky DS et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006;27:476-81. (Pubitemid 43209175)
23. Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-9.
24. de Franciscis S, Mastroroberto P, Gallelli L, Buffone G, Montemurro R, Serra R. Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm. Ann Vasc Surg 2013;27:1185.e5-7.
25. de Franciscis S, Gallelli L, Battaglia L, Molinari V, Montemurro R, Stillitano DM et al. Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease. Int Wound J 2013 [Epub ahead of print].
26. Serra R, Gallelli L, Buffone G, Molinari V, Stillitano DM, Palmieri C et al. Doxycycline speeds up healing of chronic venous ulcers. Int Wound J 2013 [Epub ahead of print].
27. Serra R, Buffone G, Falcone D, Molinari V, Scaramuzzino M, Gallelli L et al. Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen 2013;21:395-401.
28. Serra R, Buffone G, Costanzo G, Montemurro R, Scarcello E, Stillitano DM et al. Altered Metalloproteinase-9 expression as the least common denominator between Varicocele, Inguinal Hernia and Chronic Venous Disorders. Ann Vasc Surg 2013 [In press].
29. Serra R, Grande R, Buffone G, Gallelli L, de Franciscis S. The effects of minocycline on extracellular matrix in patients with chronic venous leg ulcers. Acta Pheb 2013;3:99-107.
30. Roccia F, Campolo B, Gallelli L, Spaccarotella C, Mongiardo A, Falcone D et al. Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphysema and by severe pulmonary hypertension: clinical, functional, and biomolecular findings. Clin Drug Investig 2013;33:451-7.
31. Falcone D, Gallelli L, Di Virgilio A, Tucci L, Scaramuzzino M, Terracciano R et al. Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-κB in lung cancer and in normal pulmonary tissues. Cell Prolif 2013;46:172-82.
32. Amato B, Coretti G, Compagna R, Amato M, Buffone G, Gigliotti D et al. Role of matrix metalloproteinases in non-healing venous ulcers. Int Wound J 2013; Oct 24.
33. Serra R, Buffone G, Costanzo G, Montemurro R, Perri P, Damiano R et al. Varicocele in younger as risk factor for inguinal hernia and for chronic venous disease in older: preliminary results of a prospective cohort study. Ann Vasc Surg 2013;27:329-3.
34. Sehestedt T, Jeppesen J, Hansen TW, Rasmussen S, Wachtell K, Ibsen H et al. Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts. J Hypertens 2012;30:1928-36.
35. Wood KE. A history of pulmonary embolism and deep venous thrombosis. Crit Care Clin 2009;25:115-31.
36. Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pulmonary embolism. Circulation 2006;113:577-82.
37. Brotman DJ, Deitcher SR, Lip GY, Matzdorff AC. Virchow's triad revisited. South Med J 2004;97:213-4.
38. Cervantes J, Rojas G. Virchow's Legacy: deep vein thrombosis and pulmonary embolism. World J Surg 2005;29(Suppl 1):S30-4. (Pubitemid 40991358)
39. Veyssier-Belot C, Cacoub P. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension. Cardiovasc Res 1999;44:274-82. (Pubitemid 29474090)
40. Fortuna GM, Figueiredo-Lopes L, Dias-Junior CA, Gerlach RF, Tanus-Santos JE. A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. Int J Cardiol 2007;114:22-7. (Pubitemid 44791467)
41. Battistini B. Modulation and roles of the endothelins in the pathophysiology of pulmonary embolism. Can J Physiol Pharmacol 2003;81:555-69. (Pubitemid 36836391)
42. Polikepahad S, Moore RM, Venugopal CS. Endothelins and airways - A short review. Res Commun Mol Pathol Pharmacol 2006;119:3-51. (Pubitemid 47579199)
43. Neto-Neves EM, Dias-Junior CA, Rizzi E, Castro MM, Sonego F, Gerlach RF et al. Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism. Crit Care Med 2011;39:349-56.
44. Neto-Neves EM, Kiss T, Muhl D, Tanus-Santos JE. Matrix metalloproteinases as drug targets in acute pulmonary embolism. Curr Drug Targets 2013;14:344-52.
45. Rabinovitch M. Elastase and cell matrix interactions in the pathobiology of vascular disease. Acta Paediatr Jpn 1995;37:657-66. (Pubitemid 26018727)
46. Fu LJ, Zhou AQ, Shen J, Zhao W, Li F. Effect of elastase inhibitor on pulmonary hypertension induced by monocrotaline. Honghua Er Ke Za Zhi 2004;42:375-8.
47. Yamaki S. Pulmonary vascular disease associated with pulmonary hypertension in 445 patients: diagnosis from lung biopsy and autopsy. Gen Thorac Cardiovasc Surg 2013;61:24-31.
48. Yokoyama U, Minamisawa S, Ishikawa Y. Regulation of vascular tone and remodeling of the ductus arteriosus. J Smooth Muscle Res 2010;46:77-87.
49. de Franciscis S, Agus GB, Bisacci R, Botta G, Gasbarro V, Domanin M et al. Guidelines for venous thromboembolism and clinical practice in Italy: a nationwide survey. Ann Vasc Surg 2008;22:319-27. (Pubitemid 351615264)
50. Fragomeni G, Merola A, Serra R, de Franciscis S, Amato F. A nonlinear lumped parameters model to analyze the dynamics of venous reflux. Conf Proc IEEE Eng Med Biol Soc 2008;2008:1407-10.